Appetite Suppression by GLP-1 Receptor Agonists: Role of Delayed Gastric Emptying.
Detailed measurement of stomach emptying in patients on appetite-suppressing drugs clarifies how these medications work, aiding dosing and side-effect management.
Friedman, Harmsen, and Camilleri prospectively characterised gastric emptying dynamics in patients receiving GLP-1 receptor agonists, quantifying the relative contribution of delayed gastric emptying to appetite suppression beyond direct central nervous system satiety signalling mechanisms. Findings carry implications for dosing optimisation, GI side-effect prediction and management, and identification of responder phenotypes based on baseline gastric motility characteristics.
What the study was
- Study design
- Prospective mechanistic study
- Population
- Patients receiving GLP-1 receptor agonists for obesity treatment
- Category
- Drug Development
- Maturity
- Validated
- Journal
- Obesity (Silver Spring)
Why it surfaced
Mechanistic human study elucidating GLP-1 RA mode of action; directly relevant to T7 cardiometabolic topic as GLP-1 agents are central to current pharmacotherapy.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.